Results 141 to 150 of about 3,286,932 (311)
Радиационная гигиена, 2015 Regional study was conducted in 12 specialized pediatric medical organisations in St. Petersburg to assess exposure levels of pediatric patients (newborns, 1, 5, 10 and 15 years) during the most common radiographic examinations.
I. G. Shatskii
doaj
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Molecular Oncology, EarlyView.Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source
Insights into a long life without cancer: The case of the bowhead whale
Molecular Oncology, EarlyView.Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
General Principles of Radiation Protection in Fields of Diagnostic Medical Exposure. [PDF]
J Korean Med Sci, 2016 Do KH.
europepmc +1 more source
Molecular Oncology, EarlyView.Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Molecular cancer prevention: Intercepting disease
Molecular Oncology, EarlyView.Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source
Low-doses ionizing radiation exposure: an emerging causal risk factor for cardiovascular disease [PDF]
Exploration of Cardiology, 2023 Maria Grazia Andreassi
doaj +1 more source
Molecular Oncology, EarlyView.Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Medical Radiation Exposures in Canada: 2017
Health PhysicsRadiation-based medical techniques and devices provide significant benefits to patients through the diagnosis, treatment, and management of illness and disease. Documenting trends and frequency of use offer important insights into radiation protection and help address gaps in the documentation of medical ...
Burtt, Julie J. +3 more
openaire +2 more sources